XERS Stock Ownership Activity

XERIS BIOPHARMA HOLDINGS INC 13F holders

No value investing guru has made any change to the XERIS BIOPHARMA HOLDINGS INC (XERS) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying XERS now?

According to the latest SEC filing(s) XERIS BIOPHARMA HOLDINGS INC (XERS) has not been purchased by any super investor.

To see more about who is investing in XERIS BIOPHARMA HOLDINGS INC (XERS), please go to the XERS ownership page.

2024 Q2 (1 result)
Prem Watsa
+12.91%
+19,542
+0.00%
0.03%
Current price: $3.14 40.18% Reported price*: $2.24
2021 Q4 (1 result)
Prem Watsa
buy
+151,395
+0.01%
0.01%
Current price: $3.14 7.80% Reported price*: $2.91
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.